Pharmaron Beijing Co., Ltd. Class H (17Q1) Financial Statements
Pharmaron Beijing Co., Ltd. Class H Financial Overview
Pharmaron Beijing Co., Ltd. Class H's market cap is currently $9.19B. The company's EPS TTM is $0.99; its P/E ratio is 41.79; and it has a dividend yield of 0.82%. Pharmaron Beijing Co., Ltd. Class H is estimated to report earnings on March 29, 2027, and the estimated EPS forecast is $0.06. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 14.10B | $ 12.28B | $ 11.54B | $ 10.27B | $ 7.44B |
| Gross Profit | $ 4.91B | $ 4.20B | $ 4.12B | $ 3.77B | $ 2.68B |
| Operating Income | $ 1.93B | $ 2.10B | $ 1.85B | $ 1.69B | $ 1.91B |
| EBITDA | $ 3.29B | $ 3.38B | $ 2.95B | $ 2.53B | $ 2.49B |
| Net Income | $ 1.66B | $ 1.79B | $ 1.60B | $ 1.37B | $ 1.66B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 1.73B | $ 2.81B | $ 6.72B | $ 2.24B | $ 5.10B |
| Total Assets | $ 27.09B | $ 23.93B | $ 26.48B | $ 20.49B | $ 18.39B |
| Total Debt | $ 3.42B | $ 5.54B | $ 9.36B | $ 6.12B | $ 5.29B |
| Net Debt | $ 2.40B | $ 3.85B | $ 3.44B | $ 4.62B | $ 1.74B |
| Total Liabilities | $ 11.36B | $ 9.70B | $ 13.24B | $ 9.65B | $ 8.09B |
| Stockholders' Equity | $ 15.06B | $ 13.62B | $ 12.56B | $ 10.55B | $ 10.13B |
| Cash Flow | |||||
| Free Cash Flow | $ 551.97M | $ 536.02M | $ -111.78M | $ -807.04M | $ -34.78M |
| Operating Cash Flow | $ 3.22B | $ 2.58B | $ 2.75B | $ 2.14B | $ 2.06B |
| Investing Cash Flow | $ -4.37B | $ -2.02B | $ -2.25B | $ -2.21B | $ -5.26B |
| Financing Cash Flow | $ 377.00M | $ -4.80B | $ 3.92B | $ -1.42B | $ 3.66B |
Currency in CNY
